Could Fixing the Mitochondria Be the Key to Tackling Metabolic Syndrome? 🧬

European Wellness researchers and collaborators have published a compelling new review in the American Journal of Biomedical Science & Research – exploring how mitochondrial dysfunction sits at the very heart of metabolic syndrome, and how targeted peptide therapies could help restore the body’s metabolic engine from the inside out!

📚 Publication Title: Targeting Mitochondrial Bioenergetic Failure in Metabolic Syndrome: Translational Roles of Mitochondrial and Multi-Organ Peptides
✍️ Authors: Prof. Dato’ Sri Dr. Mike K.S. Chan, Prof. Dato’ Sri Dr. Michelle B.F. Wong, Krista Casazza and Jonathan R.T. Lakey
📑 Journal: American Journal of Biomedical Science & Research – 30(4), 2026

👇 Read Here: https://european-wellness.eu/publications/targeting-mitochondrial-bioenergetic-failure/

💡 Why this matters:

• Metabolic syndrome is one of the defining health challenges of our time, and conventional approaches often target symptoms one organ at a time.
• Rather than addressing isolated symptoms, this research points toward a holistic, hypothesis-driven model that targets the root cause – cellular energy failure.
• While more clinical trials are needed, the science points toward an exciting future where peptide-based therapies could help restore the body’s natural metabolic flexibility and reduce cardiometabolic risk at its source.
• The paper explores two promising frontiers in peptide-based intervention: Mitochondrial-derived peptides and Multi-organ peptide constructs.

Read the full publication here: https://european-wellness.eu/publications/targeting-mitochondrial-bioenergetic-failure/